Skip to content

Pain, hedonic regulation, and opioid misuse: Modulation of momentary experience by Mindfulness-Oriented Recovery Enhancement in opioid-treated chronic pain patients

Eric L Garland, Craig J. Bryan, Patrick H. Finan, Elizabeth Anne Thomas, Sarah E. Priddy, Michael R. Riquino, Matthew O. Howard

Drug and Alcohol Dependence March 29, 2017 DOI: 10.1016/j.drugalcdep.2016.07.033 (opens in new tab)

Study at a glance

AI-extracted from the abstract
Characteristics Secondary analysis of ecological momentary assessment data from a randomized controlled trial Peer reviewed
Sample size 55
Population Chronic pain patients at risk for opioid misuse
Intervention Mindfulness-Oriented Recovery Enhancement (MORE)
Duration 8 weeks of treatment
Topics Meditation
Citations 74
Registration NCT01505101
Key findings Patients receiving Mindfulness-Oriented Recovery Enhancement (MORE) reported greater improvements in momentary pain and positive affect than a support group control, and were more likely to exhibit positive affect regulation (OR=2.75). Improvements in positive affect, but not pain, were associated with reduced risk of opioid misuse by post-treatment.

Abstract

Background: Given the risk of opioid misuse among chronic pain patients being treated with long-term opioid pharmacotherapy, non-pharmacological treatments are needed. Further, in light of hedonic deficits in this population, therapies that enhance positive affect may be useful. The purpose of this study was to examine effects of a Mindfulness-Oriented Recovery Enhancement (MORE) intervention on ecological momentary assessments (EMA) of pain and positive affective experience, and to determine if changes in pain, affect, and their interaction were associated with opioid misuse at post-treatment.

Methods: This study examined unpublished EMA data from a subset of participants (N=55) in a previously published RCT (NCT01505101) of MORE versus a support group (SG) control. Across 8 weeks of treatment, patients completed up to 224 EMA measures of pain and affect. Multilevel models and generalized estimating equations examined effects of treatment on momentary pain and positive affect, and generalized linear models examined associations between pain and affect and changes in opioid misuse by post-treatment.

Results: Patients in MORE reported significantly greater improvements in momentary pain (p=0.01) and positive affect (p=0.004) than patients in the SG. Further, over the entire course of treatment, patients in MORE were significantly more likely to exhibit positive affect regulation (OR=2.75) than patients in the SG. Finally, improvements in positive affect (but not pain) over the course of intervention were associated with reduced risk of misusing opioids by post-treatment (p=0.02).

Conclusion: MORE may be a useful non-pharmacological treatment for pain and hedonic deficits among chronic pain patients at risk for opioid misuse.

Comparable studies

Other randomized controlled trials on meditation, most cited first.

Study Year Design Participants
Alterations in Brain and Immune Function Produced by Mindfulness Meditation Healthy employees in a work environment 2003 Randomized controlled trial n = 41
Prevention of relapse/recurrence in major depression by mindfulness-based cognitive therapy. Recovered recurrently depressed patients 2000 Randomized controlled trial n = 145
Open hearts build lives: Positive emotions, induced through loving-kindness meditation, build consequential personal resources. Working adults 2008 Randomized controlled trial n = 139
Short-term meditation training improves attention and self-regulation Undergraduate Chinese students 2007 Randomized controlled trial n = 40
Mindfulness-Based Cognitive Therapy for Depression: Replication and Exploration of Differential Relapse Prevention Effects. Recovered recurrently depressed patients 2004 Randomized controlled trial n = 73

Citations in the library

Cited by 15

and 10 more in the library

Cites 10

and 5 more in the library

Explore topics